Comparison of Fiberoptic-Guided Tracheal Intubation Through Intubating Laryngeal Mask Airway (ILMA) FastrachTM and Ambu® Aura-i™: A Randomized Clinical Study

Mishra, Navya; Bharadwaj, Avnish

doi:10.7759/cureus.10178

Cited by 5 publications

(4 citation statements)

References 11 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean fiberoptic-guided intubation time was 14.95±1.85 seconds in Group 1 and 14.15±1.37 seconds in Group 2. The difference in times was statistically low and insignificant, in line with other investigations [ 4 , 8 - 12 ]. Group 1 took approximately 11.87 ± 1.265 seconds to remove the Ambu® Aura-i™, whereas Group 2 took 11.25±1.58 seconds, with removal times being comparable.…”

Section: Discussionsupporting

confidence: 91%

Clinical Assessment of the Ambu® Aura-i™ as an Independent Ventilatory Device and Conduit for Fiberoptic-Guided Endotracheal Intubation in Adults

Mishra,

Sinha,

Kharwar

et al. 2024

Cureus

Self Cite

View full text Add to dashboard Cite

Background and aim A novel supraglottic airway device of the second generation is the Ambu® Aura-i™. It is designed to accommodate standard cuffed tracheal tubes and is phthalate-free and compatible with MRI. The primary objectives of the research were to examine the properties and efficiency of Ambu® Aura-i™ as a means of enabling fiberoptic-guided intubation, the view of the glottis during fiber optic examination, the duration of intubation in fiber optic bronchoscopy, the ease of intubation, the success rate of intubation, and the duration for device removal from the tracheal tube. Methodology A hospital-based descriptive observational study was conducted with 80 patients. An adequately sized Ambu® Aura-i™ was placed after general anesthesia was induced. Following a fiberoptic examination of the view of the glottis through the Ambu® Aura-i™, the trachea was intubated under fiberoptic guidance. The Ambu® Aura-i™ insertion time, glottic view grading, ease of intubation, and time required for fiberoptic-guided intubation were recorded. Also, the time taken to remove the Ambu® Aura-i™ was documented. Results Similar levels of ease were experienced by both groups after inserting the Ambu® Aura-i™, being easy in both group 1 (37/40) and in group 2 (38/40). In group 1, the average time taken to insert the Ambu® Aura-i™ was 13.53±1.91 seconds, while in group 2, it was 13.98±2.4 seconds. The average time required for fiberoptic-guided intubation was found to be 14.95±1.85 seconds in group 1 and 14.15±1.37 seconds in group 2, indicating a statistically negligible variation. Conclusion The low cost of Ambu® Aura-i™, size suitability and availability for almost all age groups, compatibility with MRI machines, and availability in phthalate-free versions contribute to it being a more appealing and useful ventilatory device, as well as an intubation tool for both normal and emergency airway management.

show abstract

Section: Discussionsupporting

confidence: 91%

Clinical Assessment of the Ambu® Aura-i™ as an Independent Ventilatory Device and Conduit for Fiberoptic-Guided Endotracheal Intubation in Adults

Mishra,

Sinha,

Kharwar

et al. 2024

Cureus

Self Cite

View full text Add to dashboard Cite

show abstract

“…The first-attempt success rate of SaCoVLM insertion was 92.7% (95%CI = 1.03–1.13) in children, which confirms that the success rate of devices insertion is lower than that in adults with normal airway [ 13 , 14 ], This may be due to the anatomical differences in children with microtia, which may existing a narrow laryngeal space. After manual adjustment [ 15 ] and reinsertion, the final success rate of device insertion can reach 100%.…”

Section: Discussionmentioning

confidence: 99%

Preliminary evaluation of SaCoVLM video laryngeal mask-guided intubation in airway management for anesthetized children

et al. 2023

View full text Add to dashboard Cite

Backgrounds To preliminary evaluate the application of novel SaCoVLM video laryngeal mask -guided intubation for anesthetized children. Methods One hundred twenty-four children with microtia (ages 5-15 years,) who required general intubation anaesthesia, were enrolled in the study. After induction of general anesthesia,guided tracheal intubation under direct vision of the SaCoVLM was performed. Our primary outcome was first-pass success rate of guided tracheal tube placement. Secondary outcome included glottic visualization grades, the first-attempt success rate of LMA placement, the time for LMA placement and time to endotracheal intubation as well as the time for LMA removal after successful intubation, the fiberoptic grade of laryngeal view, the baseline and postinduction hemodynamic parameters were also recorded,and the incidence 24 h complications after operation. Results The first-pass success rate of guided tracheal tube placement was 91.1% (95%CI = 1.04–1.14), the status of glottic visualization was classified: grade 1 in 27cases, grade 2 in 36 cases, grade 3 in 41 cases and grade 4 in 20 cases. The first success rate of LMA placement was 92.7% (95%CI = 1.03–1.13), the time for LMA insertion was 15.7 (±9.1) s, intubation time was 30.9 (±17.6) s and withdrawl time was 24.9 (±9.3) s. The incidence of postoperative sore throat at 2 h was 29%, and 16.1% at 24 h, without dysphagia and hypoxia. Conclusion The SaCoVLM video laryngeal mask-guided intubation is feasible in children, with a high success rate, could be a new promising device to guide intubation in airway management. Trial registration This study was approved by the University’s Institutional Review Board and written informed consent was obtained from all subjects participating in the trial. The trial was registered prior to patient enrollment at clinicaltrials.gov (ChiCTR2200061481, http://www.chictr.org.cn. Principal investigator: Juan Zhi; Date of registration: 26/06/2022.

show abstract

“…FBI through a SAD can be performed under continuous oxygenation to increase patient safety and at the same time provide the anaesthesiologist with sufficient time for the procedure 2 . Most trials have investigated FBI through SADs in the hands of anaesthesiologists experienced in this procedure 3–8 or have failed to report level of experience 9–12 . However, the performance of anaesthesiologists with limited experience in this technique has not been examined 13 .…”

Section: Introductionmentioning

confidence: 99%

“…2 Most trials have investigated FBI through SADs in the hands of anaesthesiologists experienced in this procedure [3][4][5][6][7][8] or have failed to report level of experience. [9][10][11][12] However, the performance of anaesthesiologists with limited experience in this technique has not been examined. 13 In a life-threatening situation, anaesthesiologists should have the most reliable and user-friendly SAD available as a first-line equipment.…”

mentioning

confidence: 99%

AuraGain™ versus i‐gel™ for bronchoscopic intubation under continuous oxygenation: A randomised controlled trial

Svendsen

Rosenstock

Glargaard

et al. 2022

Acta Anaesthesiol Scand

View full text Add to dashboard Cite

Introduction After failed mask ventilation and tracheal intubation, guidelines issued by the Difficult Airway Society recommend placing a second generation supraglottic airway device to secure oxygenation. Ultimately, a secure airway can be obtained by tracheal intubation through the supraglottic airway device using a bronchoscope. In this randomised trial, we compared the AuraGain™ with the i‐gel™ as conduit for bronchoscopic intubation under continuous oxygenation performed by a group of anaesthesiologists with variable experience in a general population of patients. Method We randomised one hundred patients who were equally allocated to flexible bronchoscopic intubation through the i‐gel™ or the AuraGain™. In a random order, 25 anaesthesiologists each performed four intubations, two using the i‐gel™ and two using the AuraGain™. Our primary outcome was ‘total time for airway management’; i.e. total time from manually reaching the SAD to successful FBI confirmed at the end of the first inspiratory downstroke on the capnography curve. Results In total, 87% (95% CI, 79%–92%) of the patients were successfully intubated through the allocated supraglottic airway device. There was no difference in total time for airway management between the i‐gel™ and the AuraGain™ (199 vs. 227 s, p = .076). However, there was a difference in time for placement of the i‐gel™, compared to the AuraGain™, (37 vs. 54 s, p < .001). There were nine failed intubations in the AuraGain™ group compared to four in the i‐gel™ group (p = .147). Conclusion We found no difference in total time for airway management between using the i‐gel™ and using the AuraGain™.

show abstract

Comparison of Fiberoptic-Guided Tracheal Intubation Through Intubating Laryngeal Mask Airway (ILMA) FastrachTM and Ambu® Aura-i™: A Randomized Clinical Study

Cited by 5 publications

References 11 publications

Clinical Assessment of the Ambu® Aura-i™ as an Independent Ventilatory Device and Conduit for Fiberoptic-Guided Endotracheal Intubation in Adults

Clinical Assessment of the Ambu® Aura-i™ as an Independent Ventilatory Device and Conduit for Fiberoptic-Guided Endotracheal Intubation in Adults

Preliminary evaluation of SaCoVLM video laryngeal mask-guided intubation in airway management for anesthetized children

AuraGain™ versus i‐gel™ for bronchoscopic intubation under continuous oxygenation: A randomised controlled trial

Contact Info

Product

Resources

About